Influence of Argon Plasma Coagulation on weight loss in patients with weight regain after Stomach Reduction Surgery

Influence of Argon Plasma Coagulation on weight loss in patients with weight regain after Bariatric Y Roux Surgery: Randomized clinical trial

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

REBEC

Registry ID

RBR-7p4dtq

Enrollment

Unknown

Registered

2020-09-17

Start date

2020-02-07

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric surgery

Interventions

Four groups (10 randomized individuals in each group): Experimental groups: argon plasma coagulation and 7-day liquid diet

argon plasma coagulation and 20-day liquid diet

Control groups: endoscopy with phantom procedure and 7-day liquid diet

and endoscopy with phantom procedure and a 20-day liquid diet. Argon plasma coagulation: Argon plasma application over the entire circumference of the gastrojejunal anastomosis by means of an endoscop

Procedure/surgery

Other

D01.268.613.050

E01.370.388.250

Eligibility

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Individuals over 18 years of age with a history of regain weight of at least 10% of their weight after bariatric Y-Roux surgery performed for at least 18 months

Exclusion criteria

Exclusion criteria: Individuals with impossibility of endoscopic handling in the gastrointestinal tract; verification of anastomosis diameter less than 2.0 cm; severe organic pathologies, such as neoplasms, chronic obstructive pulmonary disease, renal failure, heart failure and cirrhosis; pregnancy or intention to become pregnant in the 12 months after the CPA procedure; inability to return to clinical care after the CPA procedure; and non-adherence to medical treatment.

Design outcomes

Primary

Measure	Time frame
Percentage of weight loss measured by weight in kg, 3 and 6 months after the procedure with argon plasma or phantom	—

Secondary

Measure	Time frame
Body composition, measured through measurements made by the adipometer and by means of an electrical bioimpedance device, 3 and 6 months after the procedure with argon plasma or phantom ;Dietary intake, measured through a 24-hour recall 3 and 6 months after the procedure with argon plasma or phantom ;Gastrointestinal symptoms measured through self-report, 3 and 6 months after the procedure with argon plasma or phantom	—

Measure

Time frame

Body composition, measured through measurements made by the adipometer and by means of an electrical bioimpedance device, 3 and 6 months after the procedure with argon plasma or phantom ;Dietary intake, measured through a 24-hour recall 3 and 6 months after the procedure with argon plasma or phantom ;Gastrointestinal symptoms measured through self-report, 3 and 6 months after the procedure with argon plasma or phantom

—

Countries

Brazil

Contacts

Public Contactmariana moraes

Faculdade de Medicina de Botucatu

mari_bordinhon@hotmail.com14998779108

Outcome results

None listed

Source: REBEC (via WHO ICTRP)